Craig I Coleman

The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes

Effie L. Gillespie, C Michael White, Michael J. Kardas et al. · Diabetes Care · 2005 · 220 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

François Laliberté, Michel Cloutier, Winnie W. Nelson et al. · Current Medical Research and Opinion · 2014 · 185 citations

Medicine, Cardiology, Pharmacotherapy +17

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

Elizabeth S. Mearns, Diana M Sobieraj, C Michael White et al. · PLoS ONE · 2015 · 141 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Soyon Lee, Moise Anglade, Robyn Pisacane et al. · The American Journal of Cardiology · 2012 · 129 citations

Medicine, Pharmacoeconomics, Pharmacotherapy +14

Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors

Benjamin Miao, Adrían V. Hernández, Mark J. Alberts et al. · Journal of the American Heart Association · 2020 · 127 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +13